Literature DB >> 15467823

Vasohibin: the feedback on a new inhibitor of angiogenesis.

Robert S Kerbel1.   

Abstract

Angiogenesis is regulated in large part by the balance of various proangiogenic stimulators, such as VEGF, and a diverse group of endogenous inhibitors of angiogenesis, most of which are extrinsic to endothelial cells. With respect to the latter, until recently, none have appeared to be induced as a consequence of a specific, self-regulating, feedback inhibition response. A new inhibitor, called vasohibin, has been uncovered. Vasohibin is selectively induced in endothelial cells by proangiogenic stimulatory growth factors such as VEGF; it appears to operate as an intrinsic and highly specific feedback inhibitor of activated endothelial cells engaged in the process of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467823      PMCID: PMC518673          DOI: 10.1172/JCI23153

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.

Authors:  D Hanahan; G Bergers; E Bergsland
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis.

Authors:  R Kalluri
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

3.  Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis.

Authors: 
Journal:  Trends Cell Biol       Date:  1997-05       Impact factor: 20.808

Review 4.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 5.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

6.  In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.

Authors:  S Filleur; O V Volpert; A Degeorges; C Voland; F Reiher; P Clézardin; N Bouck; F Cabon
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

7.  Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor.

Authors:  Olga V Volpert; Tetiana Zaichuk; Wei Zhou; Frank Reiher; Thomas A Ferguson; P Michael Stuart; Mohammad Amin; Noel P Bouck
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline.

Authors:  Wojciech Kalas; Sarah Gilpin; Joanne L Yu; Linda May; Halka Krchnakova; Paul Bornstein; Janusz Rak
Journal:  Biochem Biophys Res Commun       Date:  2003-10-10       Impact factor: 3.575

9.  SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Authors:  Stéphanie Filleur; Aurélie Courtin; Slimane Ait-Si-Ali; Julien Guglielmi; Carole Merle; Annick Harel-Bellan; Philippe Clézardin; Florence Cabon
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

10.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

View more
  13 in total

1.  Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.

Authors:  Zhanlong Shen; Hanna Seppänen; Tuuli Kauttu; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  J Interferon Cytokine Res       Date:  2013-05-07       Impact factor: 2.607

2.  Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.

Authors:  Zhanlong Shen; Tuuli Kauttu; Hanna Seppänen; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  Med Oncol       Date:  2012-03-22       Impact factor: 3.064

3.  Association between TAp73, p53 and VASH1 expression in lung adenocarcinoma.

Authors:  Meng Wu; Zhihua Zhang; Fangxu Ma; Xiulong Zhang; Zhilin Zhang; Jianhua Tang; Ping Chen; Chunyan Zhou; Weiping Wang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

4.  Vasohibin-1 suppresses colon cancer.

Authors:  Shuai Liu; Bing Han; Qunyuan Zhang; Jie Dou; Fang Wang; Wenli Lin; Yuping Sun; Guangyong Peng
Journal:  Oncotarget       Date:  2015-04-10

Review 5.  Angiogenesis in spontaneous tumors and implications for comparative tumor biology.

Authors:  C Benazzi; A Al-Dissi; C H Chau; W D Figg; G Sarli; J T de Oliveira; F Gärtner
Journal:  ScientificWorldJournal       Date:  2014-01-19

6.  The expression of vasohibin-1 and its prognostic significance in bladder cancer.

Authors:  Bo Zhang; Zhouliang Wu; Wanqin Xie; Dawei Tian; Feiran Chen; Chuan Qin; Zhiyong Du; Gang Tang; Qiongqiong Gao; Xiaoyu Qiu; Changli Wu; Jing Tian; Hailong Hu
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

7.  Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.

Authors:  Johann Kern; Michael Steurer; Günther Gastl; Eberhard Gunsilius; Gerold Untergasser
Journal:  BMC Cancer       Date:  2009-08-17       Impact factor: 4.430

8.  Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis.

Authors:  Muna Affara; Debbie Sanders; Hiromitsu Araki; Yoshinori Tamada; Benjamin J Dunmore; Sally Humphreys; Seiya Imoto; Christopher Savoie; Satoru Miyano; Satoru Kuhara; David Jeffries; Cristin Print; D Stephen Charnock-Jones
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

Review 9.  Advances and challenges in skeletal muscle angiogenesis.

Authors:  I Mark Olfert; Oliver Baum; Ylva Hellsten; Stuart Egginton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

Review 10.  The roles of vasohibin and its family members: Beyond angiogenesis modulators.

Authors:  Hua Du; Jing Zhao; Ling Hai; Jing Wu; Hua Yi; Yonghong Shi
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.